Fresenius Medical Care (NYSE:FMS; ETR:FRE) said last Thursday that Standard & Poor’s upgraded its corporate credit rating to BBB.
The Bad Homburg, Germany-based company said that S&P gave them a BBB rating with a stable outlook from BBB- with a positive outlook.
Fresenius said that it is rated as investment grade by the three leading rating agencies Standard & Poor’s, Moody’s and Fitch, according to an SEC filing.
Earlier this month, Fresenius saw shares rise slightly after the dialysis-focused device maker beat expectations on Wall Street with its first quarter earnings release.
